Cite
HARVARD Citation
Chiu, H. et al. (2019). Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma. British journal of haematology. pp. 240-253. [Online].